STAT6 and breast cancer: In conclusion, the proprietary STAT6 siRNAs used in this study silenced STAT6 expression, reduced the number of live cells and induced apoptosis in the STAT6high CRC and BC cell lines, HT-29 and ZR-75-1, respectively.